Genetic landscape of external auditory canal squamous cell carcinoma. Sato K ,Komune N ,Hongo T ,Koike K ,Niida A ,Uchi R ,Noda T ,Kogo R ,Matsumoto N ,Yamamoto H ,Masuda M ,Oda Y ,Mimori K ,Nakagawa T. Cancer Sci. 2020 Jun 5.
Therapeutic effect of Nivolumab for advanced / recurrent temporal bone squamous cell carcinoma. Noda T ,Komune N ,Yasumatsu R ,Tsuchihashi NA ,Tamae A ,Matsumoto N ,Sato K ,Uchi R ,Koike K ,Wakasaki T ,Tanaka R ,Nakagawa T. Auris Nasus Larynx. 2020 Oct;47(5):864-869.
Primary Advanced Squamous Cell Carcinoma of the Temporal Bone: A Single-Center Clinical Study. Komune N ,Noda T ,Kogo R ,Miyazaki M ,Tsuchihashi NA ,Hongo T ,Koike K ,Sato K ,Uchi R ,Wakasaki T ,Matsumoto N ,Yasumatsu R ,Nakagawa T. Laryngoscope. 2020 Apr 8.
Malignant perivascular epithelioid cell tumor mimicking jugular foramen schwannoma: A case report and literature review. Komune N ,Masuda S ,Yasumatsu R ,Hongo T ,Jiromaru R ,Matsuo S ,Akiyama O ,Tsuchihashi N ,Matsumoto N ,Yamamoto H ,Nakagawa T. Heliyon. 2020 Jan;6(1):e03200.
Asymmetrical surface scanning registration for image-guided otologic surgery: A phantom study. Matsumoto N ,Yamashita M ,Cho B ,Komune N ,Hashizume M. Auris Nasus Larynx. 2020 Aug;47(4):574-579.
Relationship between immune-related adverse events and the long-term outcomes in recurrent/metastatic head and neck squamous cell carcinoma treated with nivolumab. Matsuo M ,Yasumatsu R ,Masuda M ,Toh S ,Wakasaki T ,Hashimoto K ,Taura M ,Uchi R ,Nakagawa T. Oral Oncol. 2020 Feb;101:104525.
HPV-related Sinonasal Carcinoma: Clinicopathologic Features, Diagnostic Utility of p16 and Rb Immunohistochemistry, and EGFR Copy Number Alteration. Jiromaru R ,Yamamoto H ,Yasumatsu R ,Hongo T ,Nozaki Y ,Hashimoto K ,Taguchi K ,Masuda M ,Nakagawa T ,Oda Y. Am J Surg Pathol. 2020 Mar;44(3):305-315.
PTPN3 expressed in activated T lymphocytes is a candidate for a non-antibody-type immune checkpoint inhibitor. Fujimura A ,Nakayama K ,Imaizumi A ,Kawamoto M ,Oyama Y ,Ichimiya S ,Umebayashi M ,Koya N ,Morisaki T ,Nakagawa T ,Onishi H. Cancer Immunol Immunother. 2019 Oct;68(10):1649-1660.
Stress-triggered YAP1/SOX2 activation transcriptionally reprograms head and neck squamous cell carcinoma for the acquisition of stemness. Omori H ,Sato K ,Nakano T ,Wakasaki T ,Toh S ,Taguchi K ,Nakagawa T ,Masuda M. J Cancer Res Clin Oncol. 2019 Oct;145(10):2433-2444.
The surgical anatomy of soft tissue layers in the mastoid region. Hongo T ,Komune N ,Shimamoto R ,Nakagawa T. Laryngoscope Investig Otolaryngol. 2019 Jun;4(3):359-364.